# Aged Male Mice Remain Glucose Tolerant Despite Increased Energy Storage Efficiency Favoring Diet‐Induced Obesity

**Authors:** Liz Gray, Kaylynn Vidmar, Marita Rivir, Vishnupriya J. Borra, Diego Perez‐Tilve

PMC · DOI: 10.1111/acel.70441 · Aging Cell · 2026-03-08

## TL;DR

Older male mice can store more fat without developing glucose intolerance, but this makes them more prone to obesity.

## Contribution

The study reveals that aged mice have increased fat storage efficiency and reduced lipid turnover, which protects against glucose intolerance but increases obesity risk.

## Key findings

- Old mice on a high-fat diet gained more fat mass but remained glucose tolerant.
- Old mice showed reduced lipid turnover in visceral fat and increased plasticity in subcutaneous fat.
- Increased fat storage efficiency in old mice did not protect against weight loss during calorie restriction.

## Abstract

Obesity and aging are converging health challenges, contributing to morbidity in older populations. However, the specific contribution of age to susceptibility to obesity is unclear. This study examined the impact of age on susceptibility to diet‐induced obesity (DIO) and calorie restriction (CR) in male mice. Young (2–3 months) and old (17–24 months) lean C57BL/6J male mice were fed a standard chow diet (CD) or a high‐fat diet (HFD) for 28 days, then underwent 18 days of CR. We monitored body weight, body composition, energy intake and expenditure, glucose tolerance, and gene expression in metabolically relevant tissues. HFD‐fed old mice exhibited more fat mass gain but, surprisingly, protection from glucose intolerance. In comparison, young controls exhibited resistance to DIO due to reduced calorie storage efficiency. Gene expression analysis suggested reduced plasticity and lipid turnover in visceral adipose tissue but increased subcutaneous adipose tissue plasticity in old mice. The increased energy storage did not protect old mice from body weight loss following CR. Old mice exhibit increased susceptibility to DIO due to near optimal efficiency storing calories as fat. This susceptibility correlates with increased energy storage efficiency and the absence of energy demanding anabolic processes, like lean mass accrual, exhibited by young mice. Despite increased predisposition to obesity, lifelong leanness confers resilient glycemic control to old mice, emphasizing the importance of maintaining a healthy body weight and dietary habits throughout life to mitigate age‐related metabolic risks.

Aging enhances glycemic control during short‐term high‐fat diet but increases vulnerability to obesity due to greater fat storage efficiency, reduced lipid turnover, and increased liver fat. These changes uncouple adiposity from glycemia, sustaining glucose homeostasis while increasing obesity and steatohepatitis risks without protecting against weight loss upon calorie restriction.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Adrb3 (adrenergic receptor, beta 3) [NCBI Gene 11556] {aka Adrb-3, beta 3-AR}, G6pc1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 14377] {aka G6Pase, G6pc, G6pt, Glc-6-Pase}, Pck1 (phosphoenolpyruvate carboxykinase 1, cytosolic) [NCBI Gene 18534] {aka PEPCK, PEPCK-C, Pck-1}, Scd1 (stearoyl-Coenzyme A desaturase 1) [NCBI Gene 20249] {aka Scd, Scd-1, ab}, Insig1 (insulin induced gene 1) [NCBI Gene 231070] {aka 1810013C12Rik, Insig-1}, Slc16a3 (solute carrier family 16 (monocarboxylic acid transporters), member 3) [NCBI Gene 80879] {aka Mct3, Mct4}, Igfbp5 (insulin-like growth factor binding protein 5) [NCBI Gene 16011] {aka IGFBP-5, IGFBP-5P}, Trim63 (tripartite motif-containing 63) [NCBI Gene 433766] {aka MuRF1, RF1, Rnf28}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Mstn (myostatin) [NCBI Gene 17700] {aka Cmpt, Gdf8}, Lipe (lipase E, hormone sensitive type) [NCBI Gene 16890] {aka 4933403G17Rik, HSL, REH}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, Adrb2 (adrenergic receptor, beta 2) [NCBI Gene 11555] {aka Adrb-2, Badm, Gpcr7}, Myh2 (myosin, heavy polypeptide 2, skeletal muscle, adult) [NCBI Gene 17882] {aka MHC2A, MyHC-2a, MyHC-IIa, Myh2a, Myhs-f, Myhs-f1}, Elovl6 (ELOVL fatty acid elongase 6) [NCBI Gene 170439] {aka FAE, LCE}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Pnpla2 (patatin-like phospholipase domain containing 2) [NCBI Gene 66853] {aka 0610039C21Rik, 1110001C14Rik, Atgl, TTS-2.2}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Myh1 (myosin, heavy polypeptide 1, skeletal muscle, adult) [NCBI Gene 17879] {aka A530084A17Rik, IId, IId/x, MHC-2X/D, MHC2X/D, MYHC-IIX}, Pphln1 (periphilin 1) [NCBI Gene 223828] {aka CR, HSPC206, HSPC232}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Slc10a2 (solute carrier family 10, member 2) [NCBI Gene 20494] {aka 9130221J18Rik, ASBT, IBAT, ISBT}, Adrb1 (adrenergic receptor, beta 1) [NCBI Gene 11554] {aka Adrb-1, beta-AR}, Gipr (gastric inhibitory polypeptide receptor) [NCBI Gene 381853] {aka GIP-R, Gm1081, Gm160}, Gck (glucokinase) [NCBI Gene 103988] {aka GLK, Gk, Gls006, HK4, HKIV, HXKP}
- **Diseases:** hepatic steatosis (MESH:D005234), BW gain (MESH:D015430), DIO (MESH:D009765), overweight (MESH:D050177), fat (MESH:D004620), BW loss (MESH:D001835), fat mass (MESH:C536030), muscle atrophy (MESH:D009133), inflammation (MESH:D007249), hyperglycemia (MESH:D006943), Diabetes (MESH:D003920), impaired glucose metabolism (MESH:D044882), lean (MESH:D013851), adiposity (MESH:D018205), glucose intolerance (MESH:D018149), lipid malabsorption (MESH:D011017), malabsorption (MESH:D008286), hyperinsulinemia (MESH:D006946), hypertrophy (MESH:D006984), weight loss (MESH:D015431), insulin resistance (MESH:D007333)
- **Chemicals:** free fatty acids (MESH:D005230), Cholesterol (MESH:D002784), BG (MESH:D001786), insulin (MESH:D007328), fat (MESH:D005223), nitrogen (MESH:D009584), Triglycerides (MESH:D014280), lipid (MESH:D008055), Glucose (MESH:D005947), CD (-), Glycerol (MESH:D005990), catecholamine (MESH:D002395), carbohydrates (MESH:D002241)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967622/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967622/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967622/full.md

---
Source: https://tomesphere.com/paper/PMC12967622